EUVIMEDEUVIMED entdecken
Crossref

Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) and PLT, APTT: Predictive Value of Thrombotic Risk Assessment in SLE Patients

Peixia Yu, Hairu Wang, Yueping Li, Yanli Yang, Jiqiang Guo

Clinical Laboratory · 2024

DOI: 10.7754/clin.lab.2023.230526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Laboratory, 2024. Verfasst von Peixia Yu und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Thrombosis, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Risk assessment of vascular thrombosis in SLE patients with the presence of antiphospholipid antibodies (aPL) remains a challenge. The adjusted global antiphospholipid syndrome score (aGAPSS) has been validated and used to predict aPL-related thrombosis in SLE patients in some countries. Relevant data of aGAPSS in thrombotic evaluation in SLE population from China has not been reported. We aim to validate aGAPSS in thrombosis assessment in Chinese patients with SLE and to explore the correlations of aGAPSS with routine laboratory parameters and their clinical significance as well. METHODS: A total of 166 consecutive SLE patients were retrospectively analyzed. Multivariate logistic regression analysis was performed to examine the impact of multiple cardiovascular risk factors and laboratory parameters in recurrent thrombosis risk in SLE. ROC was conducted to explore the discriminative ability of aGAPSS and platelet (PLT), activated partial thromboplastin time (APTT), alone or in combination. RESULTS: Significantly higher value of aGAPSS was seen in SLE patients with vascular thrombosis. ROC curve indicated that aGAPSS of 3.5 or more had the best diagnostic accuracy for the prediction of aPL-related thrombosis in SLE patients. PLT with cutoff of 187.5 x 109/L and APTT with 37.5 seconds were predictors of aPL-related thrombosis as well. The combination of aGAPSS with PLT and APTT improved AUC compared to aGAPSS alone. CONCLUSIONS: The aGAPSS could predict the risk of aPL-related vascular thrombosis in SLE patients from China. The combination of aGAPSS with PLT and APTT was first time proved to have better predictive performance in thrombosis risk assessment in SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromeThrombosisLupus Erythematosus, SystemicHumansRetrospective StudiesPartial Thromboplastin TimeRisk FactorsRisk Assessment

Zitieren

APA

Yu, P., Wang, H., Li, Y., Yang, Y., & Guo, J. (2024). Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) and PLT, APTT: Predictive Value of Thrombotic Risk Assessment in SLE Patients. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2023.230526

Vancouver

Yu P, Wang H, Li Y, Yang Y, Guo J. Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) and PLT, APTT: Predictive Value of Thrombotic Risk Assessment in SLE Patients. Clinical Laboratory. 2024. doi:10.7754/clin.lab.2023.230526

BibTeX
@article{Yu2024,
  author = {Yu, Peixia and Wang, Hairu and Li, Yueping and Yang, Yanli and Guo, Jiqiang},
  title = {Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) and PLT, APTT: Predictive Value of Thrombotic Risk Assessment in SLE Patients},
  journal = {Clinical Laboratory},
  year = {2024},
  doi = {10.7754/clin.lab.2023.230526}
}
Kostenlos starten →